Alpine Immune Sciences Inc (NASDAQ:ALPN)

10.43
Delayed Data
As of Oct 22
 -0.21 / -1.97%
Today’s Change
7.21
Today|||52-Week Range
16.37
-17.22%
Year-to-Date

Today’s Trading

Previous close10.64
Today’s open10.65
Day’s range10.24 - 10.72
Volume1,685
Average volume (3 months)105,485
Market cap$272.2M
Data as of 3:59pm ET, 10/22/2021

Growth & Valuation

Earnings growth (last year)+41.15%
Earnings growth (this year)+16.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+436.49%
P/E ratioNM
Price/Sales28.11
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
SRRASierra Oncology Inc-0.30-1.46%
KMDAKamada Ltd+0.07+1.26%
PRTGPortage Biotech Inc+0.55+2.97%
LPTXLeap Therapeutics In...+0.01+0.34%
Data as of 3:59pm ET, 10/22/2021

Financials

Next reporting dateNovember 18, 2021
EPS forecast (this quarter)$0.02
Annual revenue (last year)$9.3M
Annual profit (last year)-$27.9M
Net profit margin-299.30%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Seattle, Washington

Forecasts